speb/financial-data huggingface dataset:
Financial ratios for BLNK — annual report dated 2022-12-31
Total revenue: 60843000
Gross profit: 14506000
Operating income: -89871000
Net income: -91560000
Capital expenditures: 5249000
Operating cash flow: -82365000
Depreciation & amortization: 9547000
Net tangible assets: 30665000
Owner earnings: -87262000
Return on net tangible assets (%): -284.5654655144301
Buffett classification: The Gruesome
Stock price: 10.97
Shares outstanding: 143682259
Book value: 260957000
P/B ratio: 6.040054036603732
Market cap (USD): 1576194381.23
Debt to equity: 0.02104561287875014
Current ratio: 1.9730127186009538
Quick ratio: 1.282631160572337
Interest coverage ratio: -58.777632439502945
COGS to revenue (%): 76.15830909061026
SG&A to revenue (%): 46.720247193596634
Free cash flow (dilution-adjusted): -103821000
Buyback yield (%): 0
Retained earnings: -334030000
Inventory turnover: 1.3338226827864132
Receivables turnover: 2.580170476230864
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -28.784326536887217
FCF margin (%): -170.63754252748876
Rule of 40 score: -170.63754252748876
Financial ratios for BLNK — annual report dated 2023-12-31
Total revenue: 140129000
Gross profit: 39737000
Operating income: -105340000
Net income: -203693000
Capital expenditures: 7552000
Operating cash flow: -97570000
Depreciation & amortization: 12441000
Net tangible assets: 128218000
Owner earnings: -198804000
Return on net tangible assets (%): -155.05155282409646
Buffett classification: The Gruesome
Stock price: 3.39
Shares outstanding: 143682259
Book value: 289397000
P/B ratio: 1.6830957404879803
Market cap (USD): 487082858.01
Debt to equity: 0.061990967425370684
Current ratio: 3.1812169122394227
Quick ratio: 2.4933932081318777
Interest coverage ratio: -29.70671178793006
COGS to revenue (%): 71.64255792876564
SG&A to revenue (%): 25.01409415609902
Free cash flow (dilution-adjusted): -128189000
Buyback yield (%): 0
Retained earnings: -537723000
Inventory turnover: 2.094030286596304
Receivables turnover: 3.083349836072788
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -29.35750157461443
FCF margin (%): -91.47927980646404
Revenue growth (%): 130.31244350212842
Rule of 40 score: 38.83316369566438
Financial ratios for BLNK — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.72
Shares outstanding: 143682259
Market cap (USD): 247133485.48
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BLNK — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.39
Shares outstanding: 143682259
Market cap (USD): 199718340.01
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BLNK — annual report dated 2024-12-31
Total revenue: 122989000
Gross profit: 36597000
Operating income: -73298000
Net income: -201318000
Capital expenditures: 5192000
Operating cash flow: -48291000
Depreciation & amortization: 12751000
Net tangible assets: 87231000
Owner earnings: -193759000
Return on net tangible assets (%): -222.1217227820385
Buffett classification: The Gruesome
Stock price: 1.39
Shares outstanding: 143682259
Book value: 115516000
P/B ratio: 1.7289236124000138
Market cap (USD): 199718340.01
Debt to equity: 0.09326846497454898
Current ratio: 2.345463106208381
Quick ratio: 1.7298715275442256
Interest coverage ratio: -170.06496519721577
COGS to revenue (%): 70.24368032913513
SG&A to revenue (%): 25.926708892665197
Free cash flow (dilution-adjusted): -60433000
Buyback yield (%): 0
Retained earnings: -739041000
Inventory turnover: 2.3599213286713288
Receivables turnover: 2.923298155542879
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -47.11940240939071
FCF margin (%): -49.13691468342697
Revenue growth (%): -12.231586609481264
Rule of 40 score: -61.368501292908235
Financial ratios for BLNK — quarterly report dated 2025-03-31
Total revenue: 20718000
Gross profit: 7069000
Operating income: -20702000
Net income: -21008000
Capital expenditures: 1087000
Operating cash flow: -13026000
Depreciation & amortization: 2950000
Net tangible assets: 75761000
Owner earnings: -19145000
Return on net tangible assets (%): -25.27025778434815
Buffett classification: The Gruesome
Stock price: 0.92
Shares outstanding: 143682259
Book value: 102603000
P/B ratio: 1.2883412598072181
Market cap (USD): 132187678.28
Debt to equity: 0.10073779519117375
Current ratio: 2.1458260687635122
Quick ratio: 1.4686344933398423
Interest coverage ratio: -369.67857142857144
COGS to revenue (%): 65.87991118833865
SG&A to revenue (%): 42.80335939762525
Free cash flow (dilution-adjusted): -15252000
Buyback yield (%): 0
Retained earnings: -756562000
Inventory turnover: 0.3514070183568909
Receivables turnover: 0.5506152496877242
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -14.607470964282188
FCF margin (%): -73.61714451201854
Rule of 40 score: -73.61714451201854
Financial ratios for BLNK — quarterly report dated 2025-06-30
Total revenue: 28635000
Gross profit: 2062000
Operating income: -30425000
Net income: -31959000
Capital expenditures: 2455000
Operating cash flow: -15498000
Depreciation & amortization: 2633000
Net tangible assets: 45189000
Owner earnings: -31781000
Return on net tangible assets (%): -70.3290623824382
Buffett classification: The Gruesome
Stock price: 0.94
Shares outstanding: 143682259
Book value: 70752000
P/B ratio: 1.908940008197648
Market cap (USD): 135061323.45999998
Debt to equity: 0.13520465852555405
Current ratio: 1.6980123773897153
Quick ratio: 1.134203313278974
COGS to revenue (%): 92.79902217565916
SG&A to revenue (%): 89.3312379954601
Free cash flow (dilution-adjusted): -18772000
Buyback yield (%): 0
Retained earnings: -788521000
Inventory turnover: 0.8124808903565095
Receivables turnover: 0.8251448001613694
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -27.555632036082706
FCF margin (%): -65.55613759385368
Revenue growth (%): 38.21314798725746
Rule of 40 score: -27.34298960659622
Financial ratios for BLNK — quarterly report dated 2025-09-30
Total revenue: 26971000
Gross profit: 9607000
Operating income: -11906000
Net income: -86000
Capital expenditures: 683000
Operating cash flow: -3016000
Depreciation & amortization: 2569000
Net tangible assets: 62744000
Owner earnings: 1800000
Buffett classification: The Gruesome
Stock price: 1.64
Shares outstanding: 143682259
Book value: 90780000
P/B ratio: 2.5957138660497905
Market cap (USD): 235638904.76
Debt to equity: 0.0883013879709187
Current ratio: 1.6013384164798665
Quick ratio: 1.0871279676685701
COGS to revenue (%): 64.38026027955954
SG&A to revenue (%): 20.22542731081532
Free cash flow (dilution-adjusted): -4132000
Buyback yield (%): 0
Retained earnings: -788607000
Inventory turnover: 0.55251853501766
Receivables turnover: 0.7979349723380965
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -10.80791575889615
FCF margin (%): -15.320158688962218
Revenue growth (%): -5.811070368430243
Rule of 40 score: -21.13122905739246
Financial ratios for BLNK — quarterly report dated 2025-12-31
Total revenue: 27010000
Gross profit: 6315000
Operating income: -11947000
Net income: -30633000
Capital expenditures: 5483000
Operating cash flow: 683000
Depreciation & amortization: 1444000
Net tangible assets: 56114000
Owner earnings: -34672000
Return on net tangible assets (%): -61.788501978115974
Buffett classification: The Gruesome
Stock price: 0.67
Shares outstanding: 143682259
Book value: 64490000
P/B ratio: 1.492744821367654
Market cap (USD): 96267113.53
Debt to equity: 0.1233679640254303
Current ratio: 1.4072031762036803
Quick ratio: 1.1842229644567683
COGS to revenue (%): 76.6197704553869
SG&A to revenue (%): 11.899296556830803
Free cash flow (dilution-adjusted): -5378000
Buyback yield (%): 0
Retained earnings: -822426000
Inventory turnover: 1.4622341553027627
Receivables turnover: 0.9146011106596235
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -14.225836796418237
FCF margin (%): -19.91114402073306
Revenue growth (%): 0.14459975529272182
Rule of 40 score: -19.76654426544034
Financial ratios for BLNK — annual report dated 2025-12-31
Total revenue: 103210000
Gross profit: 25193000
Operating income: -74679000
Net income: -83385000
Capital expenditures: 9708000
Operating cash flow: -30857000
Depreciation & amortization: 9596000
Net tangible assets: 56114000
Owner earnings: -83497000
Return on net tangible assets (%): -148.79887372135298
Buffett classification: The Gruesome
Stock price: 0.67
Shares outstanding: 143682259
Book value: 64490000
P/B ratio: 1.492744821367654
Market cap (USD): 96267113.53
Debt to equity: 0.1233679640254303
Current ratio: 1.4072031762036803
Quick ratio: 1.1842229644567683
COGS to revenue (%): 75.5905435519814
SG&A to revenue (%): 28.436198042825307
Free cash flow (dilution-adjusted): -43534000
Buyback yield (%): 0
Retained earnings: -822426000
Inventory turnover: 5.5124001978379145
Receivables turnover: 3.494853040769335
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -88.92368511925316
FCF margin (%): -42.18002131576398
Revenue growth (%): -16.081926025904757
Rule of 40 score: -58.26194734166874
Financial ratios for BNK.TO — annual report dated 2021-12-31
Total revenue: 10518422.83464567
Net income: 10447843.307086615
Capital expenditures: 0
Operating cash flow: 1559070.0787401574
Net tangible assets: 22445667.716535434
Owner earnings: 10447843.307086615
Return on net tangible assets (%): 46.547259983670806
Buffett classification: The Gruesome
Stock price: 5.039370078740157
P/E ratio: 0.9307173141486231
Shares outstanding: 1929604
Book value: 22445667.716535434
P/B ratio: 0.43322340792979774
Market cap (USD): 9723988.661417322
Debt to equity: 0
COGS to revenue (%): 0
SG&A to revenue (%): 0.6710086547060998
Free cash flow (dilution-adjusted): 1559070.0787401574
Buyback yield (%): 35.02262478467084
Receivables turnover: 19.735309760399954
Capitalized R&D asset: 0
FCF margin (%): 14.822279948709413
Rule of 40 score: 14.822279948709413
Financial ratios for BNK.TO — annual report dated 2022-12-31
Total revenue: -2912330.8823529407
Net income: -3017128.676470588
Capital expenditures: 0
Operating cash flow: 3819611.0294117643
Net tangible assets: 13129141.911764706
Owner earnings: -3017128.676470588
Return on net tangible assets (%): -22.98039503836128
Buffett classification: The Gruesome
Stock price: 3.661764705882353
Shares outstanding: 1929604
Book value: 13129141.911764704
P/B ratio: 0.5381734671629956
Market cap (USD): 7065755.823529411
Debt to equity: 0.011249447163256548
Free cash flow (dilution-adjusted): 3819611.0294117643
Buyback yield (%): 25.53176963733341
Receivables turnover: -29.487567004169144
Capitalized R&D asset: 0
Revenue growth (%): -127.68790462349813
Rule of 40 score: -127.68790462349813
Financial ratios for BNK.TO — annual report dated 2023-12-31
Total revenue: 1623650
Net income: 1493681.0606060605
Capital expenditures: 0
Operating cash flow: 3952175.7575757573
Net tangible assets: 11078292.424242424
Owner earnings: 1493681.0606060605
Return on net tangible assets (%): 13.482953901248045
Buffett classification: The Gruesome
Stock price: 4.371212121212121
P/E ratio: 5.646927323639636
Shares outstanding: 1929604
Book value: 11078292.424242422
P/B ratio: 0.7613726078833122
Market cap (USD): 8434708.393939395
Debt to equity: 0
COGS to revenue (%): 0
SG&A to revenue (%): 8.004738668674861
Free cash flow (dilution-adjusted): 3952175.7575757573
Buyback yield (%): 8.230530087086734
Receivables turnover: 18.217826663493252
Capitalized R&D asset: 0
FCF margin (%): 243.41303591141917
Rule of 40 score: 243.41303591141917
Financial ratios for BNK.TO — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 11559632.867132867
Buffett classification: The Gruesome
Stock price: 5.195804195804196
Shares outstanding: 1929604
Book value: 11559632.867132869
P/B ratio: 0.8673151366205339
Market cap (USD): 10025844.559440559
Debt to equity: 0
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BNK.TO — annual report dated 2024-12-31
Total revenue: 3556926.5734265735
Net income: 3471495.104895105
Capital expenditures: 0
Operating cash flow: 854507.6923076924
Net tangible assets: 11559632.867132867
Owner earnings: 3471495.104895105
Return on net tangible assets (%): 30.03118822887097
Buffett classification: The Gruesome
Stock price: 5.195804195804196
P/E ratio: 2.888048018648582
Shares outstanding: 1929604
Book value: 11559632.867132869
P/B ratio: 0.8673151366205339
Market cap (USD): 10025844.559440559
Debt to equity: 0
COGS to revenue (%): 0
SG&A to revenue (%): 2.401833908231845
Free cash flow (dilution-adjusted): 854507.6923076924
Buyback yield (%): 0
Receivables turnover: 59.82809320488843
Capitalized R&D asset: 0
FCF margin (%): 24.023765311649388
Revenue growth (%): 119.06978557118674
Rule of 40 score: 143.09355088283613
Financial ratios for BNK.TO — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 12711024.08759124
Buffett classification: The Gruesome
Stock price: 7.401459854014599
Shares outstanding: 1929604
Book value: 12711024.087591238
P/B ratio: 1.1235826823810564
Market cap (USD): 14281886.540145986
Debt to equity: 0
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CDLX — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 660.9
Shares outstanding: 5807863
Market cap (USD): 3838416656.7
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CDLX — annual report dated 2022-12-31
Total revenue: 298542000
Gross profit: 112632000
Operating income: -135538000
Net income: -465264000
Capital expenditures: 1171000
Operating cash flow: -53904000
Depreciation & amortization: 43740000
Net tangible assets: -214516000
Owner earnings: -422695000
Buffett classification: The Gruesome
Stock price: 57.8
Shares outstanding: 5807863
Book value: 211605000
P/B ratio: 1.5864203653032771
Market cap (USD): 335694481.4
Debt to equity: 1.1118026511660877
Current ratio: 1.0044106305032456
Quick ratio: 1.0044106305032456
Interest coverage ratio: -53.027386541471046
COGS to revenue (%): 62.272645054967136
R&D to revenue (%): 18.23361537070161
SG&A to revenue (%): 52.31793181528898
Free cash flow (dilution-adjusted): -112076000
Buyback yield (%): 11.915596536821711
Retained earnings: -976570000
Receivables turnover: 2.4862132429483923
Capitalized R&D asset: 54435000
ROCI (R&D-adjusted, %): -19.980391643699658
FCF margin (%): -37.54111649282178
Rule of 40 score: -37.54111649282178
Financial ratios for CDLX — annual report dated 2023-12-31
Total revenue: 309204000
Gross profit: 130378000
Operating income: -63669000
Net income: -134702000
Capital expenditures: 667000
Operating cash flow: -185000
Depreciation & amortization: 29515000
Net tangible assets: -201976000
Owner earnings: -105854000
Buffett classification: The Gruesome
Stock price: 92.1
Shares outstanding: 5807863
Book value: 134798000
P/B ratio: 3.9681907914064007
Market cap (USD): 534904182.29999995
Debt to equity: 1.9734862535052449
Current ratio: 1.3083804170634943
Quick ratio: 1.3083804170634943
Interest coverage ratio: -10.28744546776539
COGS to revenue (%): 57.83431003479903
R&D to revenue (%): 16.607805849859638
SG&A to revenue (%): 37.59168704156479
Free cash flow (dilution-adjusted): -53557000
Buyback yield (%): 0
Retained earnings: -1111272000
Receivables turnover: 2.4539805239640957
Capitalized R&D asset: 87823450
ROCI (R&D-adjusted, %): -9.693876286299616
Rosenberg metric: 0.32600349040139615
FCF margin (%): -17.32092728425247
Revenue growth (%): 3.5713567940189317
Rule of 40 score: -13.749570490233538
Financial ratios for CDLX — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 32
Shares outstanding: 5807863
Market cap (USD): 185851616
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CDLX — annual report dated 2024-12-31
Total revenue: 278298000
Gross profit: 120894000
Operating income: -63533000
Net income: -189304000
Capital expenditures: 1562000
Operating cash flow: -8824000
Depreciation & amortization: 27876000
Net tangible assets: -134149000
Owner earnings: -162990000
Buffett classification: The Gruesome
Stock price: 37.1
Shares outstanding: 5807863
Book value: 69993000
P/B ratio: 3.0784752375237527
Market cap (USD): 215471717.3
Debt to equity: 3.1667595330961666
Current ratio: 1.194877647611695
Quick ratio: 1.194877647611695
Interest coverage ratio: -7.136133887453667
COGS to revenue (%): 56.55951533967186
R&D to revenue (%): 17.82513708327045
SG&A to revenue (%): 39.213720544164886
Free cash flow (dilution-adjusted): -68489000
Buyback yield (%): 0
Retained earnings: -1300576000
Receivables turnover: 2.5996282215351276
Capitalized R&D asset: 101976390
ROCI (R&D-adjusted, %): -19.010078864754327
Rosenberg metric: -0.18468608817572832
FCF margin (%): -24.60995048473219
Revenue growth (%): -9.995342880428455
Rule of 40 score: -34.60529336516065
Financial ratios for CDLX — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 37.1
Shares outstanding: 5807863
Market cap (USD): 215471717.3
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CDLX — quarterly report dated 2025-03-31
Total revenue: 56435000
Gross profit: 21545000
Operating income: -16405000
Net income: -13282000
Capital expenditures: 119000
Operating cash flow: -6706000
Depreciation & amortization: 6923000
Net tangible assets: -139122000
Owner earnings: -6478000
Buffett classification: The Gruesome
Stock price: 18.2
Shares outstanding: 5807863
Book value: 64090000
P/B ratio: 1.649291724137931
Market cap (USD): 105703106.6
Debt to equity: 3.444000624122328
Current ratio: 1.1894411115577432
Quick ratio: 1.1894411115577432
Interest coverage ratio: -6.904461279461279
COGS to revenue (%): 61.82333658190839
R&D to revenue (%): 18.212102418711794
SG&A to revenue (%): 41.330734473287855
Free cash flow (dilution-adjusted): -19503000
Buyback yield (%): 0
Retained earnings: -1313858000
Receivables turnover: 0.5674596790411455
Capitalized R&D asset: 10278000
ROCI (R&D-adjusted, %): -3.85979797979798
FCF margin (%): -34.558341454770975
Rule of 40 score: -34.558341454770975
Financial ratios for CDLX — quarterly report dated 2025-06-30
Total revenue: 63249000
Gross profit: 29263000
Operating income: -12547000
Net income: -9283000
Capital expenditures: 322000
Operating cash flow: 1225000
Depreciation & amortization: 6917000
Net tangible assets: -143600000
Owner earnings: -2688000
Buffett classification: The Gruesome
Stock price: 16.45
Shares outstanding: 5807863
Book value: 58706000
P/B ratio: 1.627420474057166
Market cap (USD): 95539346.35
Debt to equity: 3.754505501992982
Current ratio: 1.1645463766657116
Quick ratio: 1.1645463766657116
Interest coverage ratio: -5.296327564373153
COGS to revenue (%): 53.733655868076966
R&D to revenue (%): 17.857989849641893
SG&A to revenue (%): 38.32471659630982
Free cash flow (dilution-adjusted): -10934000
Buyback yield (%): 0
Retained earnings: -1323141000
Receivables turnover: 0.654616021527634
Capitalized R&D asset: 18181260
ROCI (R&D-adjusted, %): -3.3749555195812575
Rosenberg metric: 0.7509243043393656
FCF margin (%): -17.28722983762589
Revenue growth (%): 12.074067511296182
Rule of 40 score: -5.213162326329709
Financial ratios for CDLX — quarterly report dated 2025-09-30
Total revenue: 52031000
Gross profit: 24300000
Operating income: -9691000
Net income: -72673000
Capital expenditures: 14000
Operating cash flow: 1761000
Depreciation & amortization: 6988000
Net tangible assets: -147611000
Owner earnings: -65699000
Buffett classification: The Gruesome
Stock price: 24.3
Shares outstanding: 5807863
Book value: -4704000
Market cap (USD): 141131070.9
Debt to equity: -47.07334183673469
Current ratio: 1.1374825186131299
Quick ratio: 1.1374825186131299
Interest coverage ratio: -3.3245283018867924
COGS to revenue (%): 53.29707289884876
R&D to revenue (%): 16.91107224539217
SG&A to revenue (%): 35.976629317137856
Free cash flow (dilution-adjusted): -9125000
Buyback yield (%): 0
Retained earnings: -1395814000
Receivables turnover: 0.5692420462999431
Capitalized R&D asset: 19758390
ROCI (R&D-adjusted, %): -5.832818275782701
Rosenberg metric: -0.43939796370075257
FCF margin (%): -17.537621802387036
Revenue growth (%): -17.73624879444734
Rule of 40 score: -35.27387059683438
Financial ratios for CDLX — annual report dated 2025-12-31
Total revenue: 233273000
Gross profit: 104613000
Operating income: -45705000
Net income: -103488000
Capital expenditures: 480000
Operating cash flow: 9290000
Depreciation & amortization: 27409000
Net tangible assets: -146580000
Owner earnings: -76559000
Buffett classification: The Gruesome
Stock price: 11.5
Shares outstanding: 5807863
Book value: -6508000
Market cap (USD): 66790424.5
Debt to equity: -33.084511370620774
Current ratio: 1.7512310243653528
Quick ratio: 1.7512310243653528
Interest coverage ratio: -4.299623706491063
COGS to revenue (%): 55.15426131614032
R&D to revenue (%): 17.046550608085806
SG&A to revenue (%): 36.57045607507084
Free cash flow (dilution-adjusted): -34621000
Buyback yield (%): 0
Retained earnings: -1404064000
Receivables turnover: 2.736147602514779
Capitalized R&D asset: 89947850
ROCI (R&D-adjusted, %): -17.782033813387905
Rosenberg metric: -0.3281996492430504
FCF margin (%): -14.841408992896735
Revenue growth (%): -16.178700529648076
Rule of 40 score: -31.02010952254481
Financial ratios for CDLX — quarterly report dated 2025-12-31
Total revenue: 56095000
Gross profit: 25890000
Operating income: -4098000
Net income: -8250000
Capital expenditures: 25000
Operating cash flow: 13010000
Depreciation & amortization: 6581000
Net tangible assets: -146580000
Owner earnings: -1694000
Buffett classification: The Gruesome
Stock price: 11.5
Shares outstanding: 5807863
Book value: -6508000
Market cap (USD): 66790424.5
Debt to equity: -33.084511370620774
Current ratio: 1.7512310243653528
Quick ratio: 1.7512310243653528
Interest coverage ratio: -1.3797979797979798
COGS to revenue (%): 53.84615384615385
R&D to revenue (%): 14.19912648186113
SG&A to revenue (%): 28.19859167483733
Free cash flow (dilution-adjusted): 4941000
Buyback yield (%): 0
Retained earnings: -1404064000
Receivables turnover: 0.6579595570986206
Capitalized R&D asset: 17587680
ROCI (R&D-adjusted, %): -2.439971627657661
Rosenberg metric: 0.18070235254006137
FCF margin (%): 8.80827168196809
Revenue growth (%): 7.81072821971517
Rule of 40 score: 16.61899990168326
Financial ratios for CHIB.L — annual report dated 2022-03-31
Total revenue: 3834210.526315789
Net income: 3136842.1052631577
Capital expenditures: 0
Operating cash flow: 4771052.631578947
Net tangible assets: 146335526.31578946
Owner earnings: 3136842.1052631577
Return on net tangible assets (%): 2.143595737984984
Buffett classification: The Gruesome
Stock price: 0.008815789473684211
P/E ratio: 0.08637421350671141
Shares outstanding: 30733750
Book value: 146335526.3157895
P/B ratio: 0.0018515139594479158
Market cap (USD): 270942.26973684214
Debt to equity: 0.06968484467023332
Effective tax rate (%): 0.9966777408637875
COGS to revenue (%): 0
SG&A to revenue (%): 17.36444749485244
Free cash flow (dilution-adjusted): 4771052.631578947
Buyback yield (%): 0
Receivables turnover: 0.9077881619937694
Capitalized R&D asset: 0
FCF margin (%): 124.43376801647221
Rule of 40 score: 124.43376801647221
Financial ratios for CHIB.L — annual report dated 2023-03-31
Total revenue: -18518.51851851852
Net income: -719753.086419753
Capital expenditures: 0
Operating cash flow: 4298765.432098765
Net tangible assets: 128606172.83950616
Owner earnings: -719753.086419753
Return on net tangible assets (%): -0.5596567182805195
Buffett classification: The Gruesome
Stock price: 0.008518518518518517
Shares outstanding: 30733750
Book value: 128606172.83950616
P/B ratio: 0.0020357189140931737
Market cap (USD): 261806.01851851848
Debt to equity: 0.11759510804350538
Free cash flow (dilution-adjusted): 4298765.432098765
Buyback yield (%): 37.25310241125421
Receivables turnover: -0.010760401721664276
Capitalized R&D asset: 0
Revenue growth (%): -100.48298126541091
Rule of 40 score: -100.48298126541091
Financial ratios for CHIB.L — annual report dated 2024-03-31
Total revenue: 14898734.177215189
Net income: 14205063.29113924
Capital expenditures: 0
Operating cash flow: 5884810.126582278
Net tangible assets: 136412658.22784808
Owner earnings: 14205063.29113924
Return on net tangible assets (%): 10.413302897017612
Buffett classification: The Gruesome
Stock price: 0.009240506329113924
P/E ratio: 0.01999254811976475
Shares outstanding: 30733750
Book value: 136412658.2278481
P/B ratio: 0.0020818845925431027
Market cap (USD): 283995.41139240505
Debt to equity: 0.14151030937401404
Effective tax rate (%): 0.26661926768574473
COGS to revenue (%): 0
SG&A to revenue (%): 4.401019541206457
Free cash flow (dilution-adjusted): 5884810.126582278
Buyback yield (%): 576.3152484523786
Receivables turnover: 9.783873649210308
Capitalized R&D asset: 0
FCF margin (%): 39.498725573491924
Rule of 40 score: 39.498725573491924
Financial ratios for CHIB.L — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 148522666.66666666
Buffett classification: The Gruesome
Stock price: 0.010266666666666667
Shares outstanding: 30733750
Book value: 148522666.66666666
P/B ratio: 0.0021244781941252514
Market cap (USD): 315533.1666666667
Debt to equity: 0.1369039069232979
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CHIB.L — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 150735064.93506494
Buffett classification: The Gruesome
Stock price: 0.011688311688311689
Shares outstanding: 30733750
Book value: 150735064.93506494
P/B ratio: 0.0023831591508279774
Market cap (USD): 359225.6493506494
Debt to equity: 0.13139076042941086
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CHIB.L — annual report dated 2025-03-31
Total revenue: 18912987.012987014
Net income: 18237662.337662335
Capital expenditures: 0
Operating cash flow: 6724675.324675324
Net tangible assets: 150735064.93506494
Owner earnings: 18237662.337662335
Return on net tangible assets (%): 12.09915048334568
Buffett classification: The Gruesome
Stock price: 0.011688311688311689
P/E ratio: 0.019696913052766506
Shares outstanding: 30733750
Book value: 150735064.93506494
P/B ratio: 0.0023831591508279774
Market cap (USD): 359225.6493506494
Debt to equity: 0.13139076042941086
Effective tax rate (%): 0.22735346358792186
COGS to revenue (%): 0
SG&A to revenue (%): 3.3509579070246516
Free cash flow (dilution-adjusted): 6724675.324675324
Buyback yield (%): 78.09004758612275
Receivables turnover: 11.315462315462316
Capitalized R&D asset: 0
FCF margin (%): 35.55586074297878
Revenue growth (%): 26.94358317977691
Rule of 40 score: 62.49944392275569
Financial ratios for CHIB.L — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: 166944594.5945946
Buffett classification: The Gruesome
Stock price: 0.01256756756756757
Shares outstanding: 30733750
Book value: 166944594.5945946
P/B ratio: 0.0023136327394587945
Market cap (USD): 386248.47972972976
Debt to equity: 0.123442799439853
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for COMSYN.NS — annual report dated 2024-03-31
Total revenue: 34588643.72226886
Gross profit: 7492732.941599712
Operating income: 1721033.6970859815
Net income: 942343.2066194988
Capital expenditures: 767406.1638086102
Operating cash flow: 730962.9451972658
Depreciation & amortization: 1311008.514210337
Net tangible assets: 15437630.411320303
Owner earnings: 1485945.5570212258
Return on net tangible assets (%): 9.625476950993676
Capex to operating income (%): 44.589839531205364
Buffett classification: The Good
Stock price: 0.7544385796545106
P/E ratio: 32.29550395081026
Shares outstanding: 40339200
Book value: 15437834.272694565
P/B ratio: 1.9713548037128452
Market cap (USD): 30433448.752399232
Debt to equity: 0.8431535521116457
Current ratio: 1.266450514450989
Quick ratio: 0.5409111982469144
Effective tax rate (%): 26.807436523164625
Interest coverage ratio: 1.8179135105008486
COGS to revenue (%): 78.33759252960895
SG&A to revenue (%): 7.501420598839183
Free cash flow (dilution-adjusted): -765007.7946996043
Buyback yield (%): 0
Retained earnings: 9319055.042571051
Inventory turnover: 3.131934664729821
Receivables turnover: 6.8014219015280135
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.272926983782948
FCF margin (%): -2.211731112796068
Revenue growth (%): -2.0640717732871803
Rule of 40 score: -4.275802886083248
Financial ratios for COMSYN.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 16037553.75059723
Buffett classification: The Gruesome
Stock price: 0.7520305781175347
Shares outstanding: 40339200
Book value: 16037720.974677492
P/B ratio: 1.8915600255608573
Market cap (USD): 30336311.896798857
Debt to equity: 0.9243578877437482
Current ratio: 1.2677934474652135
Quick ratio: 0.5737902029248753
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for COMSYN.NS — quarterly report dated 2024-12-31
Total revenue: 10081897.657069588
Gross profit: 4900501.223918871
Operating income: 793344.2126121925
Net income: 410164.35481990903
Capital expenditures: 0
Depreciation & amortization: 307366.8259703928
Owner earnings: 717531.1807903019
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.9249329758713135
P/E ratio: 22.741527793565986
Shares outstanding: 40339200
Market cap (USD): 37311056.30026809
Effective tax rate (%): 16.282832127902548
Interest coverage ratio: 2.4878824432503563
COGS to revenue (%): 51.39306715256565
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for COMSYN.NS — quarterly report dated 2025-03-31
Total revenue: 11431610.942249238
Gross profit: 4907575.403320083
Operating income: 1270388.122515782
Net income: 943441.6647182604
Capital expenditures: 0
Depreciation & amortization: 60673.369184007475
Net tangible assets: 17541021.74421323
Owner earnings: 1004115.0339022679
Return on net tangible assets (%): 5.724381672541536
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.8781654802193956
P/E ratio: 9.387038506043996
Shares outstanding: 40339200
Book value: 17541255.55295768
P/B ratio: 2.01949585836193
Market cap (USD): 35424492.93966624
Debt to equity: 0.7643079310007004
Current ratio: 1.3639150410793544
Quick ratio: 0.7010802576851856
Effective tax rate (%): 26.061183541462434
Interest coverage ratio: 4.932773490694508
COGS to revenue (%): 57.07013273883788
Buyback yield (%): 0
Retained earnings: 11155412.672433948
Inventory turnover: 0.6913799575557776
Receivables turnover: 2.117638906033103
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.845408055408974
Revenue growth (%): 13.38749242542856
Rule of 40 score: 13.38749242542856
Financial ratios for COMSYN.NS — annual report dated 2025-03-31
Total revenue: 40661620.29459901
Gross profit: 19119265.840542436
Operating income: 3126595.7446808508
Net income: 2001484.6855272385
Capital expenditures: 242810.38110825344
Operating cash flow: 118926.81786298807
Depreciation & amortization: 1030827.6829553425
Net tangible assets: 17541021.74421323
Owner earnings: 2789501.9873743276
Return on net tangible assets (%): 15.90273376346838
Capex to operating income (%): 7.765966595500451
Buffett classification: The Great
Stock price: 0.8781654802193956
P/E ratio: 17.69910766533524
Shares outstanding: 40339200
Book value: 17541255.55295768
P/B ratio: 2.01949585836193
Market cap (USD): 35424492.93966624
Debt to equity: 0.7643079310007004
Current ratio: 1.3639150410793544
Quick ratio: 0.7010802576851856
Effective tax rate (%): 20.045672975888593
Interest coverage ratio: 2.8572084824528607
COGS to revenue (%): 52.9795770507404
SG&A to revenue (%): 9.586466543710172
Free cash flow (dilution-adjusted): -980056.1140986672
Buyback yield (%): 0
Retained earnings: 11155412.672433948
Inventory turnover: 2.2829354652077547
Receivables turnover: 7.532326769445328
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 14.38633408802027
FCF margin (%): -2.410273144547675
Revenue growth (%): 17.55771813747138
Rule of 40 score: 15.147444992923704
Financial ratios for COMSYN.NS — quarterly report dated 2025-06-30
Total revenue: 10591294.17271238
Gross profit: 4925871.752866839
Operating income: 971167.7978001405
Net income: 649894.6875731337
Capital expenditures: 0
Depreciation & amortization: 317832.9042827054
Owner earnings: 967727.5918558391
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.5678680084249943
P/E ratio: 31.56801539473772
Shares outstanding: 40339200
Market cap (USD): 63246541.16545753
Effective tax rate (%): 15.47452365008827
Interest coverage ratio: 3.4080400771978816
COGS to revenue (%): 53.49131397409439
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -7.350816728998311
Rule of 40 score: -7.350816728998311
Financial ratios for COMSYN.NS — quarterly report dated 2025-09-30
Total revenue: 11099627.959413754
Gross profit: 5247598.647125141
Operating income: 1164859.075535513
Net income: 949560.3156708004
Capital expenditures: 0
Depreciation & amortization: 300969.5603156708
Net tangible assets: 18085558.06087937
Owner earnings: 1250529.8759864713
Return on net tangible assets (%): 6.9145219173052554
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.747012401352875
P/E ratio: 23.86441801133544
Shares outstanding: 40339200
Book value: 18311871.476888385
P/B ratio: 3.848491550937257
Market cap (USD): 70473082.66065389
Debt to equity: 0.6710304919831334
Current ratio: 1.3454250773537644
Quick ratio: 0.710556947104759
Effective tax rate (%): 1.9852906949681146
Interest coverage ratio: 4.927651659671882
COGS to revenue (%): 52.72275191282806
Buyback yield (%): 0
Inventory turnover: 0.6692621000963134
Receivables turnover: 1.522655708700386
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.342879082863415
Revenue growth (%): 4.799543647942996
Rule of 40 score: 4.799543647942996
Financial ratios for COMSYN.NS — quarterly report dated 2025-12-31
Total revenue: 10859106.605770303
Gross profit: 5214982.733652668
Operating income: 1042664.5872786009
Net income: 668686.6436448703
Capital expenditures: 0
Depreciation & amortization: 304244.17957001226
Owner earnings: 972930.8232148825
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.6090007797705248
P/E ratio: 20.209908309319406
Shares outstanding: 40339200
Market cap (USD): 64905804.255319156
Effective tax rate (%): 18.30257499047308
Interest coverage ratio: 4.337952449367382
COGS to revenue (%): 51.975950481216046
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -2.1669316712499476
Rule of 40 score: -2.1669316712499476
Financial ratios for CRT — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 7.83
Shares outstanding: 6000000
Market cap (USD): 46980000
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CRT — annual report dated 2022-12-31
Total revenue: 12493727
Operating income: 11727772
Net income: 11743236
Capital expenditures: 0
Net tangible assets: 2961955
Owner earnings: 11743236
Return on net tangible assets (%): 396.46908882815575
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 19.25
P/E ratio: 9.835449104488745
Shares outstanding: 6000000
Book value: 2961955
P/B ratio: 38.99451544672353
Market cap (USD): 115500000
Debt to equity: 0
Current ratio: 2.1086351592554404
Quick ratio: 2.1086351592554404
COGS to revenue (%): 0
SG&A to revenue (%): 6.1307166388380345
Buyback yield (%): 0
Receivables turnover: 3705.138493475682
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 296.00972247287007
Rule of 40 score: 0
Financial ratios for CRT — annual report dated 2023-12-31
Total revenue: 12300176
Operating income: 11483991
Net income: 11547888
Capital expenditures: 0
Net tangible assets: 2671583
Owner earnings: 11547888
Return on net tangible assets (%): 432.2488951307147
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 14.56
P/E ratio: 7.565019681520985
Shares outstanding: 6000000
Book value: 2671583
P/B ratio: 32.69971398979556
Market cap (USD): 87360000
Debt to equity: 0
Current ratio: 2.1663412574558363
Quick ratio: 2.1663412574558363
COGS to revenue (%): 0
SG&A to revenue (%): 6.635555458718639
Buyback yield (%): 0
Receivables turnover: 2429.9043856183325
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 312.7803729345081
Revenue growth (%): -1.549185443222827
Rule of 40 score: -1.549185443222827
Financial ratios for CRT — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 9.26
Shares outstanding: 6000000
Market cap (USD): 55560000
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CRT — annual report dated 2024-12-31
Total revenue: 6563177
Operating income: 5617565
Net income: 5677818
Capital expenditures: 0
Net tangible assets: 2433344
Owner earnings: 5677818
Return on net tangible assets (%): 233.3339634675574
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 8.86
P/E ratio: 9.362751676788513
Shares outstanding: 6000000
Book value: 2433344
P/B ratio: 21.846479577075826
Market cap (USD): 53160000
Debt to equity: 0
Current ratio: 3.6767311758880057
Quick ratio: 3.6767311758880057
COGS to revenue (%): 0
SG&A to revenue (%): 14.407839374132376
Buyback yield (%): 0
Receivables turnover: 1558.5791973402993
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 163.61788973082804
Revenue growth (%): -46.641600900670035
Rule of 40 score: -46.641600900670035
Financial ratios for CRT — quarterly report dated 2025-03-31
Total revenue: 2053394
Operating income: 1771932
Net income: 1783938
Capital expenditures: 0
Net tangible assets: 2346714
Owner earnings: 1783938
Return on net tangible assets (%): 76.01855189852704
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 12.09
P/E ratio: 10.16571203707752
Shares outstanding: 6000000
Book value: 2346714
P/B ratio: 30.91130832304235
Market cap (USD): 72540000
Debt to equity: 0
Current ratio: 2.0634338278300635
Quick ratio: 2.0634338278300635
COGS to revenue (%): 0
SG&A to revenue (%): 13.707159950793663
Buyback yield (%): 0
Receivables turnover: 550.6554035934566
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 52.94542646906787
Rule of 40 score: 0
Financial ratios for CRT — quarterly report dated 2025-06-30
Total revenue: 1293766
Operating income: 880566
Net income: 892548
Capital expenditures: 0
Net tangible assets: 2290044
Owner earnings: 892548
Return on net tangible assets (%): 38.97514632906617
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 9.22
P/E ratio: 15.494964976673524
Shares outstanding: 6000000
Book value: 2290044
P/B ratio: 24.156741093184237
Market cap (USD): 55320000.00000001
Debt to equity: 0
Current ratio: 6.3464996699117595
Quick ratio: 6.3464996699117595
COGS to revenue (%): 0
SG&A to revenue (%): 20.34370975895177
Buyback yield (%): 0
Receivables turnover: 335.1725388601036
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 25.597521427051518
Revenue growth (%): -36.99377713190942
Rule of 40 score: -36.99377713190942
Financial ratios for CRT — quarterly report dated 2025-09-30
Total revenue: 761552
Operating income: 440589
Net income: 453318
Capital expenditures: 0
Net tangible assets: 2233097
Owner earnings: 453318
Return on net tangible assets (%): 20.299969056427017
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 7.09
P/E ratio: 13.591905435611942
Shares outstanding: 6000000
Book value: 2233097
P/B ratio: 19.049777058497682
Market cap (USD): 42540000
Debt to equity: 0
Current ratio: 7.823502241258044
Quick ratio: 7.823502241258044
COGS to revenue (%): 0
SG&A to revenue (%): 22.449287770237618
Buyback yield (%): 0
Receivables turnover: 174.06902857142856
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.470334100648808
Revenue growth (%): -41.136805264630546
Rule of 40 score: -41.136805264630546
Financial ratios for CRT — quarterly report dated 2025-12-31
Total revenue: 1629528
Operating income: 1348075
Net income: 1361040
Capital expenditures: 0
Net tangible assets: 2158420
Owner earnings: 1361040
Return on net tangible assets (%): 63.05723631174656
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 7.69
P/E ratio: 10.274237982882505
Shares outstanding: 6000000
Book value: 2158420
P/B ratio: 21.376747806265698
Market cap (USD): 46140000
Debt to equity: 0
Current ratio: 3.1068538134054022
Quick ratio: 3.1068538134054022
COGS to revenue (%): 0
SG&A to revenue (%): 8.066937174445608
Buyback yield (%): 0
Receivables turnover: 357.82345191040844
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 37.35914887956502
Revenue growth (%): 113.97462024917537
Rule of 40 score: 113.97462024917537
Financial ratios for CRT — annual report dated 2025-12-31
Total revenue: 5738240
Operating income: 4441162
Net income: 4490844
Capital expenditures: 0
Net tangible assets: 2158420
Owner earnings: 4490844
Return on net tangible assets (%): 208.06163767941365
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 7.69
P/E ratio: 10.274237982882505
Shares outstanding: 6000000
Book value: 2158420
P/B ratio: 21.376747806265698
Market cap (USD): 46140000
Debt to equity: 0
Current ratio: 3.1068538134054022
Quick ratio: 3.1068538134054022
COGS to revenue (%): 0
SG&A to revenue (%): 14.761982768235557
Buyback yield (%): 0
Receivables turnover: 1260.0439174352218
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 123.07774593866567
Revenue growth (%): -12.569171911712878
Rule of 40 score: -12.569171911712878
Financial ratios for CWH — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 32.86
Shares outstanding: 63519784
Market cap (USD): 2087260102.24
Buyback yield (%): 7.486177684913807
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CWH — annual report dated 2022-12-31
Total revenue: 6967013000
Gross profit: 2262284000
Operating income: 574996000
Net income: 337832000
Capital expenditures: 201617000
Operating cash flow: 189783000
Depreciation & amortization: 80304000
Net tangible assets: -495538000
Owner earnings: 216519000
Return on net tangible assets (%): -43.69372278210753
Capex to operating income (%): 35.06407001092182
Buffett classification: The Good
Stock price: 19.84
P/E ratio: 3.730352703592318
Shares outstanding: 63519784
Book value: 247686000
P/B ratio: 5.088024815936307
Market cap (USD): 1260232514.56
Debt to equity: 15.267358671866798
Current ratio: 1.326510807139992
Quick ratio: 0.19216942339666096
Effective tax rate (%): 24.945402841496062
Interest coverage ratio: 4.882115201738894
COGS to revenue (%): 67.52863816961444
SG&A to revenue (%): 23.065609322101164
Free cash flow (dilution-adjusted): -55540000
Buyback yield (%): 6.32875275622027
Retained earnings: 221031000
Inventory turnover: 2.215180581752641
Receivables turnover: 42.80543745391988
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 19.639048848631404
FCF margin (%): -0.7971852499772858
Rule of 40 score: -0.7971852499772858
Financial ratios for CWH — annual report dated 2023-12-31
Total revenue: 6226547000
Gross profit: 1878649000
Operating income: 271018000
Net income: 52929000
Capital expenditures: 154285000
Operating cash flow: 310807000
Depreciation & amortization: 68643000
Net tangible assets: -556587000
Owner earnings: -32713000
Capex to operating income (%): 56.92795312488469
Buffett classification: The Good
Stock price: 24.82
P/E ratio: 29.78633714749948
Shares outstanding: 63519784
Book value: 257975000
P/B ratio: 6.111293880724877
Market cap (USD): 1576561038.88
Debt to equity: 14.94581257873825
Current ratio: 1.2060093262328149
Quick ratio: 0.15718085529656198
Effective tax rate (%): -7.139387069349419
Interest coverage ratio: 1.2412374911264283
COGS to revenue (%): 69.82839766567248
SG&A to revenue (%): 24.71655638349795
Free cash flow (dilution-adjusted): 86229000
Buyback yield (%): 0
Retained earnings: 195627000
Inventory turnover: 2.1282459816666983
Receivables turnover: 33.06733970971699
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.213244570240885
FCF margin (%): 1.3848606619367043
Revenue growth (%): -10.628170207232282
Rule of 40 score: -9.243309545295578
Financial ratios for CWH — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 23.28
Shares outstanding: 63519784
Market cap (USD): 1478740571.52
Buyback yield (%): 0.15932476902140202
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CWH — annual report dated 2024-12-31
Total revenue: 6099974000
Gross profit: 1825496000
Operating income: 171189000
Net income: -38637000
Capital expenditures: 38261000
Operating cash flow: 245159000
Depreciation & amortization: 81190000
Net tangible assets: -426930000
Owner earnings: 4292000
Capex to operating income (%): 22.350151002692932
Buffett classification: The Great
Stock price: 20.37
Shares outstanding: 63519784
Book value: 484949000
P/B ratio: 2.6681114923012523
Market cap (USD): 1293898000.0800002
Debt to equity: 7.511016622366475
Current ratio: 1.3511914676921173
Quick ratio: 0.26737884246546006
Interest coverage ratio: 0.7267166174941099
COGS to revenue (%): 70.07370851088874
SG&A to revenue (%): 25.78891319864642
Free cash flow (dilution-adjusted): 122992000
Buyback yield (%): 0
Retained earnings: 132241000
Inventory turnover: 2.3462461241044066
Receivables turnover: 33.583877467874956
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.379368857674813
FCF margin (%): 2.0162708890234615
Revenue growth (%): -2.0327960264332705
Rule of 40 score: -0.016525137409808988
Financial ratios for CWH — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 20.37
Shares outstanding: 63519784
Market cap (USD): 1293898000.0800002
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CWH — quarterly report dated 2025-03-31
Total revenue: 1413524000
Gross profit: 429628000
Operating income: 19639000
Net income: -12280000
Capital expenditures: 64864000
Operating cash flow: -232479000
Depreciation & amortization: 22544000
Net tangible assets: -455822000
Owner earnings: -54600000
Capex to operating income (%): 330.2815825653037
Buffett classification: The Gruesome
Stock price: 15.74
Shares outstanding: 63519784
Book value: 458811000
P/B ratio: 2.1791138402523043
Market cap (USD): 999801400.16
Debt to equity: 8.294559197578089
Current ratio: 1.2554677597421
Quick ratio: 0.19250356508518834
Interest coverage ratio: 0.40213362819173987
COGS to revenue (%): 69.60589278993494
SG&A to revenue (%): 27.409863575008274
Free cash flow (dilution-adjusted): -311844000
Buyback yield (%): 0
Retained earnings: 112140000
Inventory turnover: 0.4642838773122861
Receivables turnover: 5.2760560331152275
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.622754726470231
FCF margin (%): -22.06145774673794
Rule of 40 score: -22.06145774673794
Financial ratios for CWH — quarterly report dated 2025-06-30
Total revenue: 1975948000
Gross profit: 592255000
Operating income: 131347000
Net income: 57523000
Capital expenditures: 44409000
Operating cash flow: 187884000
Depreciation & amortization: 23419000
Net tangible assets: -425625000
Owner earnings: 36533000
Return on net tangible assets (%): -8.58337738619677
Capex to operating income (%): 33.81044104547497
Buffett classification: The Good
Stock price: 16.86
P/E ratio: 23.670922755785426
Shares outstanding: 63519784
Book value: 516579000
P/B ratio: 2.07314574971108
Market cap (USD): 1070943558.24
Debt to equity: 7.228861413259153
Current ratio: 1.2587116436823642
Quick ratio: 0.24289451402763637
Effective tax rate (%): 24.15616264964928
Interest coverage ratio: 2.534433188615533
COGS to revenue (%): 70.02679220303368
SG&A to revenue (%): 22.140714229321826
Free cash flow (dilution-adjusted): 129453000
Buyback yield (%): 0
Retained earnings: 134525000
Inventory turnover: 0.6713176075607911
Receivables turnover: 6.551790682020896
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.152895821746747
FCF margin (%): 6.551437588438562
Revenue growth (%): 39.788783211321494
Rule of 40 score: 46.340220799760054